AIG vs LAB · P/E 21, rev $7.18B vs rev $174.4M
American International Group Inc (AIG) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported AIG revenue for 2024-12-31 was $7.18B. Net income was $901.0M. Revenue was up 6.3% from 2024-09-30 to 2024-12-31. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the AIG and LAB stock pages for the full models.
Not investment advice.